Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127074672 | 12707467 | 2 | F | 201606 | 20160825 | 20160901 | 20160902 | EXP | PHHY2016BR118453 | SANDOZ | 92.02 | YR | F | Y | 63.00000 | KG | 20160902 | CN | COUNTRY NOT SPECIFIED | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127074672 | 12707467 | 1 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH 5 CM2, QD | Y | 0 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | |||||
127074672 | 12707467 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH 15 CM2, QD | Y | 0 | 13.3 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | |||||
127074672 | 12707467 | 3 | PS | NEOTIAPIM | QUETIAPINE | 1 | Oral | 25 MG, QD | 78679 | 25 | MG | FILM-COATED TABLET | QD | ||||||
127074672 | 12707467 | 4 | SS | NEOTIAPIM | QUETIAPINE | 1 | Oral | 50 MG, QD | 78679 | 50 | MG | FILM-COATED TABLET | QD | ||||||
127074672 | 12707467 | 5 | SS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | 0.5 DF, QD | 0 | .5 | DF | TABLET | QD | ||||||
127074672 | 12707467 | 6 | SS | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | 1 DF, QD, BEFORE DINNER | 0 | 1 | DF | TABLET | QD | ||||||
127074672 | 12707467 | 7 | SS | HEIMER | MEMANTINE HYDROCHLORIDE | 1 | Oral | UNK UNK, BID | 0 | TABLET | BID | ||||||||
127074672 | 12707467 | 8 | SS | HEIMER | MEMANTINE HYDROCHLORIDE | 1 | Oral | UNK, QD | 0 | TABLET | QD | ||||||||
127074672 | 12707467 | 9 | C | ALOIS | MEMANTINE | 1 | Oral | UNK UNK, BID | 0 | TABLET | BID | ||||||||
127074672 | 12707467 | 10 | C | ALOIS | MEMANTINE | 1 | Oral | UNK, QD | 0 | TABLET | QD | ||||||||
127074672 | 12707467 | 11 | C | QUEROPAX | QUETIAPINE FUMARATE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | TABLET | QD | ||||||
127074672 | 12707467 | 12 | C | QUEROPAX | QUETIAPINE FUMARATE | 1 | Oral | 0.5 DF (100 MG), QD | 0 | .5 | DF | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127074672 | 12707467 | 1 | Dementia Alzheimer's type |
127074672 | 12707467 | 5 | Aggression |
127074672 | 12707467 | 7 | Dementia |
127074672 | 12707467 | 9 | Dementia |
127074672 | 12707467 | 11 | Sleep disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127074672 | 12707467 | OT |
127074672 | 12707467 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127074672 | 12707467 | Aggression | |
127074672 | 12707467 | Agitation | |
127074672 | 12707467 | Asthenia | |
127074672 | 12707467 | Blood pressure increased | |
127074672 | 12707467 | Cerebrovascular accident | |
127074672 | 12707467 | Decreased appetite | |
127074672 | 12707467 | Dementia | |
127074672 | 12707467 | Dizziness | |
127074672 | 12707467 | Emotional disorder | |
127074672 | 12707467 | Fall | |
127074672 | 12707467 | Fatigue | |
127074672 | 12707467 | Gait disturbance | |
127074672 | 12707467 | Headache | |
127074672 | 12707467 | Ischaemia | |
127074672 | 12707467 | Movement disorder | |
127074672 | 12707467 | Muscular weakness | |
127074672 | 12707467 | Screaming | |
127074672 | 12707467 | Sluggishness |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127074672 | 12707467 | 1 | 200701 | 0 | ||
127074672 | 12707467 | 5 | 2009 | 0 | ||
127074672 | 12707467 | 7 | 2007 | 0 |